A. D. Beadell Investment Counsel Inc. Buys New Position in Grail, Inc. (NASDAQ:GRAL)

A. D. Beadell Investment Counsel Inc. purchased a new position in Grail, Inc. (NASDAQ:GRAL) during the 4th quarter, Holdings Channel reports. The fund purchased 24,138 shares of the company’s stock, valued at approximately $430,000.

Separately, Douglas Lane & Associates LLC purchased a new stake in shares of Grail in the 4th quarter worth $3,034,000.

Insider Buying and Selling

In other news, CEO Robert P. Ragusa sold 123,454 shares of the company’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $14.02, for a total transaction of $1,730,825.08. Following the sale, the chief executive officer now directly owns 612,661 shares of the company’s stock, valued at $8,589,507.22. This represents a 16.77 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Aaron Freidin sold 30,452 shares of the firm’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $14.02, for a total transaction of $426,937.04. Following the completion of the transaction, the chief financial officer now directly owns 268,277 shares of the company’s stock, valued at approximately $3,761,243.54. This trade represents a 10.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Grail Stock Up 0.2 %

Shares of Grail stock traded up $0.04 during trading hours on Friday, hitting $17.70. The company’s stock had a trading volume of 198,609 shares, compared to its average volume of 534,286. The stock has a 50 day moving average price of $17.88. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $24.92.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. Guggenheim began coverage on Grail in a research report on Thursday, October 17th. They set a “neutral” rating on the stock. Wolfe Research began coverage on Grail in a research note on Friday, November 15th. They set a “peer perform” rating for the company. Finally, Morgan Stanley started coverage on shares of Grail in a research note on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 target price on the stock.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.